icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Treatment outcomes for hepatitis C genotype 1 infection with direct acting antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Stefan Mauss1, Peter Buggisch2, Klaus H.W. Böker3, Eckart Schott4, Hartwig Klinker5, Rainer Günther6, Heike Pfeiffer-Vornkahl7, Thomas Berg8, Christoph Sarrazin9, Dietrich Hüppe10, Michael P. Manns11, German Hepatitis C-Registry12
1Center for HIV and Hepatogastroenterology, Duesseldorf; 2ifi-institute for interdisciplinary medicine, Hamburg; 3Hepatologische Praxis, Hannover; 4Charité Campus Virchow-Klinikum (CVK), Berlin; 5University Hospital Würzburg, Würzburg; 6Universitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel; 7e.factum GmbH, Butzbach; 8University Hospital Leipzig, Leipzig; 9University Hospital Frankfurt, Germany; 10Hepatologische Schwerpunktpraxis Herne, Herne; 11Hannover Medical School, Hannover; 12Leberstiftungs-GmbH Deutschland, Hannover

HCV1

HCV2

HCV3

HCV4